XML 25 R13.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2

Accrued Expenses and Other Current Liabilities

3 Months Ended

Mar. 31, 2024

Accrued Expenses and Other Current Liabilities

Accrued Expenses and Other Current Liabilities

Note 6 – Accrued Expenses and Other Current Liabilities

As of March 31, 2024 and December 31, 2023, accrued expenses and other current liabilities consisted of the following:

​

​	​	​	​	​	​	​
​		March 31,			December 31,
​		2024			2023
Accrued intangible asset milestone obligations	​	$	4,000,000	​	$	—
Accrued defective clinical supply settlement	​	​	500,000	​	​	100,000
Accrued research and development expenses	​	​	116,388	​	​	89,872
Accrued professional services	​	​	113,479	​	​	63,028
Credit card payable	​	​	16,789	​	​	27,193
Accrued franchise tax	​	​	5,000	​	​	—
Other	​	​	99	​	​	7,835
Total accrued expenses and other current liabilities	​	$	4,751,755	​	$	287,928

​

X

- Definition

The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.

+ References

No definition available.

+ Details

Name:	us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration